$CRAI
CRA INTERNATIONAL, INC. Stock $crai

$crai Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000105370624000013 Filed on May 02, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$171.4M	$171.8M
YoY Change	12.17%
Cost Of Revenue	$125.3M	$118.9M
YoY Change	16.22%
Gross Profit	$46.12M	$52.91M
YoY Change	2.46%
Gross Profit Margin	26.9%	30.8%
Selling, General & Admin	$32.02M	$30.50M
YoY Change	12.84%
% of Gross Profit	69.43%	57.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.811M	$2.792M
YoY Change	-4.49%
% of Gross Profit	6.1%	5.28%
Operating Expenses	$32.02M	$30.50M
YoY Change	12.84%
Operating Profit	$11.29M	$19.62M
YoY Change	-17.56%
Interest Expense	$1.483M	$464.0K
YoY Change	159.72%
% of Operating Profit	13.14%	2.37%
Other Income/Expense, Net
YoY Change
Pretax Income	$9.614M	$19.01M
YoY Change	-23.66%
Income Tax	$3.076M	$5.321M
% Of Pretax Income	32.0%	27.99%
Net Earnings	$6.538M	$13.69M
YoY Change	-26.69%
Net Earnings / Revenue	3.81%	7.97%
Basic Earnings Per Share
Diluted Earnings Per Share	$0.94	$1.95
COMMON SHARES
Basic Shares Outstanding	6.916M shares	6.965M shares
Diluted Shares Outstanding	6.911M shares	7.011M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$24.65M	$37.12M
YoY Change	-30.6%
Cash & Equivalents	$24.65M	$37.12M
Short-Term Investments
Other Short-Term Assets	$15.75M	$14.29M
YoY Change	33.88%
Inventory
Prepaid Expenses
Receivables	$140.1M	$139.1M
Other Receivables	$14.21M	$14.72M
Total Short-Term Assets	$271.2M	$275.4M
YoY Change	4.99%
LONG-TERM ASSETS
Property, Plant & Equipment	$36.82M	$36.83M
YoY Change	-15.82%
Goodwill	$93.90M	$93.85M
YoY Change	0.34%
Intangibles	$7.981M	$6.851M
YoY Change	-3.04%
Long-Term Investments
YoY Change
Other Assets	$1.990M	$2.187M
YoY Change	-19.69%
Total Long-Term Assets	$274.8M	$277.1M
YoY Change	-9.53%
TOTAL ASSETS
Total Short-Term Assets	$271.2M	$275.4M
Total Long-Term Assets	$274.8M	$277.1M
Total Assets	$546.0M	$552.5M
YoY Change	-2.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$23.00M	$33.35M
YoY Change	0.66%
Accrued Expenses	$113.3M	$106.0M
YoY Change	8.47%
Deferred Revenue	$2.153M	$2.683M
YoY Change	-43.19%
Short-Term Debt	$87.00M	$70.00M
YoY Change	-13.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$252.7M	$236.8M
YoY Change	-0.43%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$100.5M	$102.9M
YoY Change	-9.03%
Total Long-Term Liabilities	$101.6M	$104.0M
YoY Change	-8.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$252.7M	$236.8M
Total Long-Term Liabilities	$101.6M	$104.0M
Total Liabilities	$354.3M	$340.8M
YoY Change	-3.01%
SHAREHOLDERS EQUITY
Retained Earnings	$205.4M	$225.1M
YoY Change	-2.54%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$191.7M	$211.8M
YoY Change
Total Liabilities & Shareholders Equity	$546.0M	$552.5M
YoY Change	-2.85%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$6.538M	$13.69M
YoY Change	-26.69%
Depreciation, Depletion And Amortization	$2.811M	$2.792M
YoY Change	-4.49%
Cash From Operating Activities	$1.807M	-$63.08M
YoY Change	-102.58%
INVESTING ACTIVITIES
Capital Expenditures	$2.316M	$730.0K
YoY Change	312.1%
Acquisitions
YoY Change
Other Investing Activities	-$1.500M	$0.00
YoY Change	163.16%
Cash From Investing Activities	-$3.816M	-$730.0K
YoY Change	237.1%
FINANCING ACTIVITIES
Cash Dividend Paid		$3.075M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-10.35M	$56.05M
YoY Change	-113.83%
NET CHANGE
Cash From Operating Activities	1.807M	-$63.08M
Cash From Investing Activities	-3.816M	-$730.0K
Cash From Financing Activities	-10.35M	$56.05M
Net Change In Cash	-12.36M	-$8.464M
YoY Change	-403.59%
FREE CASH FLOW
Cash From Operating Activities	$1.807M	-$63.08M
Capital Expenditures	$2.316M	$730.0K
Free Cash Flow	-$509.0K	-$63.81M
YoY Change	-99.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	118880000	usd
CY2023Q2	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	107837000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	30499000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	28372000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2792000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2943000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	19618000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	13693000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	464000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	571000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-142000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-528000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	19012000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	12594000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5321000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3676000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	13691000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	8918000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.97
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.25
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.95
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.23
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6926000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7119000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7011000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7252000	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	13691000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	8918000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1105000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1052000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	12586000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	9970000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37122000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45586000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5201000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4335000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	139062000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	142729000	usd
CY2024Q1	crai	Allowance For Unbilled Services AllowanceForUnbilledServices	896000	usd
CY2023Q4	crai	Allowance For Unbilled Services AllowanceForUnbilledServices	1629000	usd
CY2024Q1	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	70251000	usd
CY2023Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	56827000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14286000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11575000	usd
CY2024Q1	crai	Forgivable Loans Current ForgivableLoansCurrent	14718000	usd
CY2023Q4	crai	Forgivable Loans Current ForgivableLoansCurrent	8759000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	275439000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	265476000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36833000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	38176000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	93853000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	93989000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6851000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7196000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	84706000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	86887000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	13998000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	13885000	usd
CY2024Q1	crai	Forgivable Loans Noncurrent ForgivableLoansNoncurrent	38675000	usd
CY2023Q4	crai	Forgivable Loans Noncurrent ForgivableLoansNoncurrent	45182000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2187000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2420000	usd
CY2024Q1	us-gaap	Assets Assets	552542000	usd
CY2023Q4	us-gaap	Assets Assets	553211000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	33350000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	28701000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	106008000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	171040000	usd
CY2024Q1	us-gaap	Deferred Credits And Other Liabilities Current DeferredCreditsAndOtherLiabilitiesCurrent	9080000	usd
CY2023Q4	us-gaap	Deferred Credits And Other Liabilities Current DeferredCreditsAndOtherLiabilitiesCurrent	12289000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	16743000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	16475000	usd
CY2024Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	1590000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	7582000	usd
CY2024Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	70000000	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	236771000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	236087000	usd
CY2024Q1	crai	Deferred Compensation Liability Classified And Other Liabilities Noncurrent DeferredCompensationLiabilityClassifiedAndOtherLiabilitiesNoncurrent	13967000	usd
CY2023Q4	crai	Deferred Compensation Liability Classified And Other Liabilities Noncurrent DeferredCompensationLiabilityClassifiedAndOtherLiabilitiesNoncurrent	11681000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	88961000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	92280000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1053000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1062000	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	103981000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	105023000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2023Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6889298	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6889298	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6934265	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6934265	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	225077000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	224283000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-13287000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-12182000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	211790000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	212101000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	552542000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	553211000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	13691000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	8918000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2792000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2943000	usd
CY2024Q1	crai	Right Of Use Asset Amortization RightOfUseAssetAmortization	3565000	usd
CY2023Q2	crai	Right Of Use Asset Amortization RightOfUseAssetAmortization	3570000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-157000	usd
CY2023Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-236000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1039000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	940000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	663000	usd
CY2023Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	208000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	20000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2529000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-17659000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	13623000	usd
CY2023Q2	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	19012000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2552000	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-875000	usd
CY2024Q1	crai	Increase Decrease In Forgivable Loans IncreaseDecreaseInForgivableLoans	-523000	usd
CY2023Q2	crai	Increase Decrease In Forgivable Loans IncreaseDecreaseInForgivableLoans	9982000	usd
CY2024Q1	crai	Increase Decrease In Obligation Incentive Cash Awards IncreaseDecreaseInObligationIncentiveCashAwards	2383000	usd
CY2023Q2	crai	Increase Decrease In Obligation Incentive Cash Awards IncreaseDecreaseInObligationIncentiveCashAwards	1929000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-69302000	usd
CY2023Q2	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-73233000	usd
CY2024Q1	crai	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-4423000	usd
CY2023Q2	crai	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-4402000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-63080000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-70051000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	730000	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	562000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	usd
CY2023Q2	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	570000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-730000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1132000	usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	70000000	usd
CY2023Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	105000000	usd
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2023Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	5000000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1631000	usd
CY2023Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1873000	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	3075000	usd
CY2023Q2	us-gaap	Payments Of Dividends PaymentsOfDividends	2702000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	9242000	usd
CY2023Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	20577000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	56052000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	74848000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-706000	usd
CY2023Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	407000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8464000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4072000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45586000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31447000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37122000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35519000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	454000	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	23000	usd
CY2024Q1	crai	Excise Tax On Share Repurchases ExciseTaxOnShareRepurchases	65000	usd
CY2023Q2	crai	Excise Tax On Share Repurchases ExciseTaxOnShareRepurchases	173000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1955000	usd
CY2023Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1534000	usd
CY2023Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1081000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	91000	usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet	124000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	5569000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	5474000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	212101000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	13691000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1105000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2024Q1	crai	Stock Issued During Period Value Share Based Compensation Employees And Non Employees StockIssuedDuringPeriodValueShareBasedCompensationEmployeesAndNonEmployees	1039000	usd
CY2024Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1631000	usd
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	9242000	usd
CY2024Q1	crai	Accrued Excise Tax On Shares Repurchased Net AccruedExciseTaxOnSharesRepurchasedNet	65000	usd
CY2024Q1	crai	Dividends Share Based Compensation Net DividendsShareBasedCompensationNet	-77000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.42
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	152845000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	171789000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	152845000	usd
CY2024Q1	us-gaap	Dividends Cash DividendsCash	3075000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	211790000	usd
CY2024Q1	crai	Number Of Broad Areas Of Consulting Services NumberOfBroadAreasOfConsultingServices	2	area
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates</span></div>The preparation of financial statements in conformity with U.S. GAAP requires management to make significant estimates and judgments that affect the reported amounts of assets and liabilities, as well as the related disclosure of contingent assets and liabilities, at the date of the financial statements, and the reported amounts of consolidated revenues and expenses during the reporting period. Estimates in these condensed consolidated financial statements include, but are not limited to, allowances for accounts receivable and unbilled services, revenue recognition on fixed-price contracts, variable consideration to be included in the transaction price of revenue contracts, the useful life of long-lived assets, measurement of operating lease right-of-use assets and liabilities, share-based compensation, valuation of contingent consideration liabilities, valuation of acquired intangible assets, goodwill, accrued and deferred income taxes, valuation allowances on deferred tax assets, accrued incentive compensation, and certain other accrued expenses. These items are monitored and analyzed by CRA for changes in facts and circumstances, and material changes in these estimates could occur in the future. Changes in estimates are recorded in the period in which they become known. CRA bases its estimates on historical experience and various other assumptions that CRA believes to be reasonable under the circumstances. Actual results may differ from those estimates if CRA’s assumptions based on past experience or other assumptions do not turn out to be substantially accurate
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	171789000	usd
CY2023Q4	crai	Forgivable Loans ForgivableLoans	53941000	usd
CY2022Q4	crai	Forgivable Loans ForgivableLoans	56456000	usd
CY2024Q1	us-gaap	Contract With Customer Receivable Credit Loss Expense Reversal ContractWithCustomerReceivableCreditLossExpenseReversal	663000	usd
CY2023Q2	us-gaap	Contract With Customer Receivable Credit Loss Expense Reversal ContractWithCustomerReceivableCreditLossExpenseReversal	0	usd
CY2024Q1	crai	Reimbursable Expenses Subject To Reimbursement ReimbursableExpensesSubjectToReimbursement	17061000	usd
CY2023Q2	crai	Reimbursable Expenses Subject To Reimbursement ReimbursableExpensesSubjectToReimbursement	13981000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2683000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6037000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4703000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	5139000	usd
CY2024Q1	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	2847000	usd
CY2023Q2	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	2638000	usd
CY2024Q1	crai	Forgivable Loans Interest Rate ForgivableLoansInterestRate	0.0600
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2024Q1	crai	Forgivable Loans Advances ForgivableLoansAdvances	5250000	usd
CY2023	crai	Forgivable Loans Advances ForgivableLoansAdvances	23342000	usd
CY2024Q1	crai	Forgivable Loans Repayments ForgivableLoansRepayments	0	usd
CY2023	crai	Forgivable Loans Repayments ForgivableLoansRepayments	1816000	usd
CY2024Q1	crai	Forgivable Loans Amortization ForgivableLoansAmortization	5772000	usd
CY2023	crai	Forgivable Loans Amortization ForgivableLoansAmortization	24198000	usd
CY2024Q1	crai	Forgivable Loans Translation Adjustments ForgivableLoansTranslationAdjustments	-26000	usd
CY2023	crai	Forgivable Loans Translation Adjustments ForgivableLoansTranslationAdjustments	157000	usd
CY2024Q1	crai	Forgivable Loans ForgivableLoans	53393000	usd
CY2023Q4	crai	Forgivable Loans ForgivableLoans	53941000	usd
CY2024Q1	crai	Forgivable Loans Current ForgivableLoansCurrent	14718000	usd
CY2023Q4	crai	Forgivable Loans Current ForgivableLoansCurrent	8759000	usd
CY2024Q1	crai	Forgivable Loans Noncurrent ForgivableLoansNoncurrent	38675000	usd
CY2023Q4	crai	Forgivable Loans Noncurrent ForgivableLoansNoncurrent	45182000	usd
CY2023Q4	us-gaap	Goodwill Gross GoodwillGross	165882000	usd
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	71893000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	93989000	usd
CY2024Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2024Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-136000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	93853000	usd
CY2024Q1	us-gaap	Goodwill Gross GoodwillGross	165700000	usd
CY2024Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	71900000	usd
CY2024Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	300000	usd
CY2023Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	400000	usd
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	196000	shares
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	81503000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	143647000	usd
CY2024Q1	crai	Allocated Share Based Compensation Expense Current Accelerated Vesting Of Awards AllocatedShareBasedCompensationExpenseCurrentAcceleratedVestingOfAwards	8105000	usd
CY2023Q4	crai	Allocated Share Based Compensation Expense Current Accelerated Vesting Of Awards AllocatedShareBasedCompensationExpenseCurrentAcceleratedVestingOfAwards	16556000	usd
CY2024Q1	crai	Accrued Project Costs Current AccruedProjectCostsCurrent	2158000	usd
CY2023Q4	crai	Accrued Project Costs Current AccruedProjectCostsCurrent	1704000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	14242000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9133000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	106008000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	171040000	usd
CY2024Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	56600000	usd
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	121200000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.280
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.292
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	13691000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8918000	usd
CY2024Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	46000	usd
CY2023Q2	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	34000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	13645000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	8884000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6926000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7119000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	85000	shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	133000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7011000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7252000	shares
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.97
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.25
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.95
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.23
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	190000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1056000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	-934000	usd
CY2024Q1	crai	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Accretion FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAccretion	0	usd
CY2023	crai	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Accretion FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAccretion	68000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	190000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	190000	usd
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0001053706-24-000013-index-headers.html	Edgar Link	pending
0001053706-24-000013-index.html	Edgar Link	pending
0001053706-24-000013.txt	Edgar Link	pending
0001053706-24-000013-xbrl.zip	Edgar Link	pending
crai-20240330.htm	Edgar Link	pending
crai-20240330.xsd	Edgar Link	pending
craiq1-202410xqexx311.htm	Edgar Link	pending
craiq1-202410xqexx312.htm	Edgar Link	pending
craiq1-202410xqexx321.htm	Edgar Link	pending
craiq1-202410xqexx322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
crai-20240330_def.xml	Edgar Link	unprocessable
crai-20240330_lab.xml	Edgar Link	unprocessable
crai-20240330_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
crai-20240330_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
crai-20240330_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRAI
CRA INTERNATIONAL, INC. Stock $crai

2024 Q2 Form 10-Q Financial Statement

#000105370624000013 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRAI CRA INTERNATIONAL, INC. Stock $crai

2024 Q2 Form 10-Q Financial Statement

#000105370624000013 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRAI
CRA INTERNATIONAL, INC. Stock $crai